A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
Clinical trial NCT03541174 · COMPLETED
Trial details
- NCT number
- NCT03541174
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-18
- Primary completion
- 2021-05-14
- Enrollment
- 730
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.